EDGAR Filing Documents for 0000902219-17-000034

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0000902219-17-000034

Filing Date

2017-02-09

Accepted

2017-02-09 09:52:23

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SEC SCHEDULE 13G	SEC13G_Filing.htm	SC 13G/A	36021
	Complete submission text file	0000902219-17-000034.txt		37898

Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210

Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000

WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

IRS No.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142

Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200

ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 17585089
SIC: 2834 Pharmaceutical Preparations